Impact of Bevacizumab in Ovarian Cancer

Robert L. Coleman, MD, FACOG, FACS

Robert L. Coleman, MD, FACOG, FACS, professor, Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, discusses a study which examined the impact of bevacizumab in ovarian cancer.